ReviewSkeletal radiology2025
Whole-body MRI in arthritis.
Review in Skeletal radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Whole-body magnetic resonance imaging in rheumatology: advancements, key applications and future perspectives.La Radiologia medica · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Whole-body MRI (wbMRI) is an advanced scan modality which provides high-contrast resolution images of the entire body for screening, diagnosis, staging, and surveillance purposes. Thanks to recent technological advancements, wbMRI has gained increasing attention as a valuable tool for diagnosing and monitoring systemic arthritides by virtue of its comprehensive coverage. This technology is particularly beneficial for inflammatory conditions like rheumatoid arthritis, seronegative spondyloarthropathy, juvenile idiopathic arthritis, and chronic aseptic osteitis, all characterized by multifocal involvement of both skeletal and extra-skeletal sites. Unlike conventional MRI targeting symptomatic areas, wbMRI enables concurrent early detection also of subclinical disease foci, providing a more accurate assessment of the total disease burden. Compared to plain radiography, conventional ultrasound, and targeted MRI, wbMRI offers better sensitivity and reproducibility, particularly for intraosseous findings and axial involvement. In addition, wbMRI can be tailored to specific clinical needs through customizable scan protocols, and the lack of ionizing radiation makes it ideal for monitoring autoimmune diseases also in sensitive cohorts. Although wbMRI holds great potential for improving diagnostic accuracy and patient outcomes in inflammatory arthritis, further research is needed to validate standard scan protocols, to confirm their cost-effectiveness, and to integrate them into routine clinical practice. The present article aims to overview the current wbMRI technology and discuss it in the context of inflammatory arthritis. A general wbMRI protocol for non-oncologic musculoskeletal application is also provided.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.